All Stories

  1. Giving editors and institutions some CLUEs about research integrity cases

    Article • European Science Editing, July 2021, Pensoft Publishers

    Dr Elizabeth Wager

  2. Cooperation & Liaison between Universities & Editors (CLUE): recommendations on best practice

    Article • Research Integrity and Peer Review, April 2021, Springer Science + Business Media

    Professor Ksenija Bazdaric, Dr Elizabeth Wager

  3. Good Practice for Conference Abstracts and Presentations: GPCAP

    Article • Research Integrity and Peer Review, June 2019, Springer Science + Business Media

    Dr Jackie Marchington, Dr Elizabeth Wager

  4. UK universities compliance with the Concordat to Support Research Integrity: findings from cross-sectional time-series

    Article • March 2019, PeerJ

    Dr Elizabeth Wager

  5. UK universities compliance with the Concordat to Support Research Integrity: findings from cross-sectional time-series

    Article • March 2019, PeerJ

    Dr Elizabeth Wager

  6. A cross-sectional bibliometric study showed suboptimal journal endorsement rates of STROBE and its extensions

    Article • Journal of Clinical Epidemiology, November 2018, Elsevier

    Dr Elizabeth Wager

  7. Plagiarism in research: a survey of African medical journals

    Article • BMJ Open, November 2018, BMJ

    Dr Elizabeth Wager

  8. Response to letter to the editor by Mc Sween-Cadieux et al (2017)

    Article • Journal of Clinical Epidemiology, March 2018, Elsevier

    Dr Elizabeth Wager

  9. No difference in knowledge obtained from infographic or plain language summary of a Cochrane systematic review: three randomized controlled trials

    Article • Journal of Clinical Epidemiology, December 2017, Elsevier

    Dr Elizabeth Wager

  10. Authorship, plagiarism and conflict of interest: views and practices from low/middle-income country health researchers

    Article • BMJ Open, November 2017, BMJ

    Dr Elizabeth Wager

  11. The STROBE extensions: protocol for a qualitative assessment of content and a survey of endorsement

    Article • BMJ Open, October 2017, BMJ

    Dr Elizabeth Wager

  12. Cooperation And Liaison Between Universities And Editors (CLUE): Recommendations On Best Practice

    Article • May 2017, Cold Spring Harbor Laboratory Press

    Dr Elizabeth Wager, Professor Ksenija Bazdaric

  13. Why we should worry less about predatory publishers and more about the quality of research and training at our academic institutions

    Article • Journal of Epidemiology, February 2017, Elsevier

    Dr Elizabeth Wager

  14. Do declarative titles affect readers’ perceptions of research findings? A randomized trial

    Article • August 2016, Springer Science + Business Media

    Dr Elizabeth Wager

  15. Cochrane review on preventing research misconduct

    Article • Cochrane Database of Systematic Reviews, April 2016, Wiley

    Dr Elizabeth Wager

  16. Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study

    Article • BMJ Open, February 2016, BMJ

    Dr Elizabeth Wager, Chris Winchester

  17. Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensus

    Article • BMJ Open, January 2016, BMJ

    Dr Elizabeth Wager, Dr Mario Malicki

  18. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3

    Article • Annals of Internal Medicine, September 2015, American College of Physicians

    Dr Elizabeth Wager

  19. Too much of a good thing? An observational study of prolific authors

    Article • PeerJ, August 2015, PeerJ

    Dr Elizabeth Wager

  20. Retraction policies of top scientific journals ranked by impact factor

    Article • Journal of the Medical Library Association JMLA, July 2015, Medical Library Association

    Dr Elizabeth Wager

  21. Are prolific authors too much of a good thing?

    Article • BMJ, July 2015, BMJ

    Dr Elizabeth Wager

  22. Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meeting

    Article • BMJ Open, May 2015, BMJ

    Dr Elizabeth Wager

  23. Why are retractions so difficult?

    Article • Science Editing, February 2015, Korean Council of Science Editors

    Dr Elizabeth Wager

  24. Publication Ethics: Whose Problem is It?

    Article • PRILOZI, January 2015, De Gruyter

    Dr Elizabeth Wager

  25. How Should Journal Editors Respond to Cases of Suspected Misconduct?

    Article • PRILOZI, January 2015, De Gruyter

    Dr Elizabeth Wager

  26. Responsible Research Publication: International Standards for Editors

    Article • PRILOZI, January 2015, De Gruyter

    Dr Elizabeth Wager

  27. Responsible Research Publication: International Standards for Authors

    Article • PRILOZI, January 2015, De Gruyter

    Dr Elizabeth Wager

  28. Extent of Non-Publication in Cohorts of Studies Approved by Research Ethics Committees or Included in Trial Registries

    Article • PLOS One, December 2014, PLOS

    Dr Joerg Meerpohl, Dr Elizabeth Wager, Dr Mario Malicki

  29. Uploading garbage files to the DOI system of a journal: a new type of misconduct

    Article • Learned Publishing, October 2014, Wiley

    Dr Sun Huh, Dr Elizabeth Wager

  30. Why should clinical trials be registered?

    Article • European Journal of Anaesthesiology, August 2014, Wolters Kluwer Health

    Dr Elizabeth Wager

  31. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey

    Article • BMJ Open, April 2014, BMJ

    Dr Elizabeth Wager

  32. Publicação responsável de pesquisa: padrões internacionais para editores

    Article • Cadernos de Pesquisa, March 2014, FapUNIFESP (SciELO)

    Dr Elizabeth Wager

  33. Publicação responsável de pesquisa: padrões internacionais para autores

    Article • Cadernos de Pesquisa, March 2014, FapUNIFESP (SciELO)

    Dr Elizabeth Wager

  34. Fate of Articles That Warranted Retraction Due to Ethical Concerns: A Descriptive Cross-Sectional Study

    Article • PLOS One, January 2014, PLOS

    Dr Elizabeth Wager

  35. Reducing waste from incomplete or unusable reports of biomedical research

    Article • The Lancet, January 2014, Elsevier

    Dr Elizabeth Wager

  36. Defining and responding to plagiarism

    Article • Learned Publishing, January 2014, Wiley

    Dr Elizabeth Wager

  37. "Hardly worth the effort"? Medical journals' policies and their editors' and publishers' views on trial registration and publication bias: quantitative and qualitative study

    Article • BMJ, September 2013, BMJ

    Dr Elizabeth Wager

  38. Defining publication bias: protocol for a systematic review of highly cited articles and proposal for a new framework

    Article • Systematic Reviews, May 2013, Springer Science + Business Media

    Dr Joerg Meerpohl, Dr Elizabeth Wager

  39. The UK should lead the way on research integrity

    Article • BMJ, April 2013, BMJ

    Dr Elizabeth Wager

  40. Interventions to prevent misconduct and promote integrity in research and publication

    Article • February 2013, Wiley

    Dr Elizabeth Wager

  41. Publication ethics: whose problem is it?

    Article • Insights the UKSG journal, November 2012, UKSG

    Dr Elizabeth Wager

  42. The Committee on Publication Ethics (COPE): Objectives and achievements 1997–2012

    Article • La Presse Médicale, September 2012, Elsevier

    Dr Elizabeth Wager

  43. Cooperation between research institutions and journals on research integrity cases: Guidance from the Committee on Publication Ethics (COPE)

    Article • Maturitas, June 2012, Elsevier

    Dr Elizabeth Wager

  44. Who is responsible for investigating suspected research misconduct?

    Article • Anaesthesia, May 2012, Wiley

    Dr Elizabeth Wager

  45. Who is responsible for investigating suspected research misconduct?

    Article • Anaesthesia, March 2012, Wiley

    Dr Elizabeth Wager

  46. Editorial code of conduct

    Article • The Lancet, February 2012, Elsevier

    Dr Elizabeth Wager

  47. Research misconduct in the UK

    Article • BMJ, January 2012, BMJ

    Dr Elizabeth Wager

  48. Why has the committee on publication ethics developed guidelines for cooperation between journals and research institutions?

    Article • Saudi Journal of Anaesthesia, January 2012, Medknow

    Dr Elizabeth Wager

  49. Why Has COPE Developed Guidelines for Cooperation Between Journals and Research Institutions

    Article • Medical Archives, January 2012, ScopeMed International Medical Journal Management and Indexing System

    Dr Elizabeth Wager

  50. Publishing ethics and integrity

    Article • January 2012, Elsevier

    Dr Elizabeth Wager

  51. Cooperation Between Research Institutions and Journals on Research Integrity Cases: Guidance from the Committee on Publication Ethics COPE

    Article • Acta Informatica Medica, January 2012, ScopeMed International Medical Journal Management and Indexing System

    Dr Elizabeth Wager

  52. Cooperation between research institutions and journals on research integrity cases: Guidance from the committee on publication ethics

    Article • Saudi Journal of Anaesthesia, January 2012, Medknow

    Dr Elizabeth Wager

  53. How journals can prevent, detect and respond to misconduct

    Article • Notfall + Rettungsmedizin, October 2011, Springer Science + Business Media

    Dr Elizabeth Wager

  54. Coping with scientific misconduct

    Article • BMJ, October 2011, BMJ

    Dr Elizabeth Wager

  55. Exploring Why and How Journal Editors Retract Articles: Findings From a Qualitative Study

    Article • Science and Engineering Ethics, July 2011, Springer Science + Business Media

    Dr Elizabeth Wager

  56. Ethical issues in preparing and publishing systematic reviews

    Article • Journal of Evidence-Based Medicine, May 2011, Wiley

    Dr Elizabeth Wager

  57. Why and how do journals retract articles? An analysis of Medline retractions 1988-2008

    Article • Journal of Medical Ethics, April 2011, BMJ

    Dr Elizabeth Wager

  58. JAMA Published Fewer Industry-Funded Studies after Introducing a Requirement for Independent Statistical Analysis

    Article • PLOS One, October 2010, PLOS

    Dr Elizabeth Wager

  59. Enhancing transparency and efficiency in reporting industry-sponsored clinical research: report from the Medical Publishing Insights and Practices initiative

    Article • International Journal of Clinical Practice, May 2010, Wiley

    Dr Elizabeth Wager

  60. Competing interests of professional societies

    Article • BMJ, January 2010, BMJ

    Dr Elizabeth Wager

  61. Retractions: Guidance from the Committee on Publication Ethics (COPE)

    Article • International Journal of Polymer Analysis and Characterization, January 2010, Taylor & Francis

    Dr Elizabeth Wager

  62. The Committee on Publication Ethics Flowcharts

    Article • CHEST Journal, January 2010, Elsevier

    Dr Elizabeth Wager

  63. Retractions: guidance from the Committee on Publication Ethics (COPE)

    Article • Obesity Reviews, January 2010, Wiley

    Dr Elizabeth Wager

  64. Retractions: Guidance from the Committee on Publication Ethics (COPE)

    Article • Maturitas, December 2009, Elsevier

    Dr Elizabeth Wager

  65. Retractions: Guidance from the Committee on Publication Ethics (COPE)

    Article • Croatian Medical Journal, December 2009, Croatian Medical Journal

    Dr Elizabeth Wager

  66. Retractions: Guidance from the Committee on Publication Ethics

    Article • Journal of Critical Care, December 2009, Elsevier

    Dr Elizabeth Wager

  67. Lessons from a case of overlapping publications

    Article • Sexually Transmitted Infections, July 2009, BMJ

    Dr Elizabeth Wager

  68. Science journal editors' views on publication ethics: results of an international survey

    Article • Journal of Medical Ethics, May 2009, BMJ

    Dr Elizabeth Wager, Ian Rowlands

  69. What Should Be Done To Tackle Ghostwriting in the Medical Literature?

    Article • PLoS Medicine, February 2009, PLOS

    Dr Elizabeth Wager

  70. Recognition, reward and responsibility: Why the authorship of scientific papers matters

    Article • Maturitas, February 2009, Elsevier

    Dr Elizabeth Wager

  71. Medical editors and trial reporting: A betrayal of patient care

    Article • Journal of the Royal Society of Medicine, January 2009, SAGE Publications

    Dr Elizabeth Wager

  72. Technical editing of research reports in biomedical journals

    Article • Cochrane Database of Systematic Reviews, October 2008, Wiley

    Ms Philippa F Middleton, Dr Elizabeth Wager

  73. Reporting the findings of clinical trials: a discussion paper

    Article • Bulletin of the World Health Organization, June 2008, WHO Press

    Dr Elizabeth Wager

  74. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration

    Article • Journal of Chinese Integrative Medicine, March 2008, Journal of Chinese Integrative Medicine Press

    Dr Elizabeth Wager

  75. CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration

    Article • PLoS Medicine, January 2008, PLOS

    Ms Philippa F Middleton, Dr Elizabeth Wager

  76. CONSORT for reporting randomised trials in journal and conference abstracts

    Article • The Lancet, January 2008, Elsevier

    Ms Philippa F Middleton, Dr Elizabeth Wager

  77. Ethical publishing: the innocent author's guide to avoiding misconduct

    Article • September 2007, SAGE Publications

    Dr Elizabeth Wager

  78. Making medical messages stick

    Article • Journal of the Royal Society of Medicine, August 2007, SAGE Publications

    Dr Elizabeth Wager

  79. Technical editing of research reports in biomedical journals

    Article • April 2007, Wiley

    Ms Philippa F Middleton, Dr Elizabeth Wager

  80. Authors, Ghosts, Damned Lies, and Statisticians

    Article • PLoS Medicine, January 2007, PLOS

    Dr Elizabeth Wager

  81. Best Practice Guidelines on Publication Ethics: a Publisher's Perspective

    Article • International Journal of Clinical Practice, November 2006, Wiley

    Dr Elizabeth Wager

  82. Publishing Clinical Trial Results: The Future Beckons

    Article • PLoS Clinical Trials, October 2006, PLOS

    Dr Elizabeth Wager

  83. What is it for? Analysing the purpose of peer review.

    Article • Nature, January 2006, Nature

    Dr Elizabeth Wager

  84. Article • BMC Medicine, January 2006, Springer Science + Business Media

    Dr Elizabeth Wager

  85. A concern that drug companies cannot ignore

    Article • Journal of the Royal Society of Medicine, October 2005, SAGE Publications

    Dr Elizabeth Wager

  86. Good practice for publishing the results of clinical trials

    Article • Menopause International, September 2005, SAGE Publications

    Dr Elizabeth Wager

  87. Response to “The corporate coauthor”

    Article • Journal of General Internal Medicine, July 2005, Springer Science + Business Media

    Dr Elizabeth Wager

  88. Comments on EuropeanMedical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications

    Article • Current Medical Research and Opinion, April 2005, Informa Healthcare

    Dr Elizabeth Wager

  89. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications

    Article • Current Medical Research and Opinion, February 2005, Informa Healthcare

    Dr Elizabeth Wager

  90. The need for trial identifiers

    Article • Current Medical Research and Opinion, January 2004, Informa Healthcare

    Dr Elizabeth Wager

  91. Integrity and bias in academic psychiatry

    Article • The British Journal of Psychiatry, November 2003, Royal College of Psychiatrists

    Dr Elizabeth Wager

  92. Technical editing of research reports in biomedical journals

    Article • Cochrane Database of Systematic Reviews, January 2003, Wiley

    Dr Elizabeth Wager

  93. Raising the quality of publications: Now we have GPP!

    Article • The Quality Assurance Journal, January 2003, Wiley

    Dr Elizabeth Wager

  94. Good publication practice for pharmaceutical companies: why we need another set of guidelines

    Article • Current Medical Research and Opinion, January 2003, Informa Healthcare

    Dr Elizabeth Wager

  95. Good publication practice for pharmaceutical companies

    Article • Current Medical Research and Opinion, January 2003, Informa Healthcare

    Dr Elizabeth Wager

  96. Shortcomings of peer review in biomedical journals

    Article • Learned Publishing, October 2001, Wiley

    Dr Elizabeth Wager

  97. Realities of trial registration: the Glaxo Wellcome experience

    Article • International Journal of Pharmaceutical Medicine, January 2000, Springer Science + Business Media

    Dr Elizabeth Wager

  98. Cardiac arrhythmias reported during treatment with cisapride

    Article • Pharmacoepidemiology and Drug Safety, January 1999, Wiley

    Dr Elizabeth Wager

  99. Ghostwriting

    Article • The Lancet, June 1998, Elsevier

    Dr Elizabeth Wager

  100. A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV study

    Article • European Journal of Clinical Pharmacology, April 1997, Springer Science + Business Media

    Dr Elizabeth Wager